p-Toluenesulfonic acid monohydrate → 3-[3-(2-{[4-(1,4'-bipiperidin-1'-yl)-2-(methyloxy)phenyl]amino}-4-pyrimidinyl)-8-fluoroimidazo[1,2-a]pyridin-2-yl]-N-(2,6-difluorophenyl)benzamide
Reaction equation
Cl[C:2]1[N:7]=[C:6]([C:8]2[N:12]3[CH:13]=[CH:14][CH:15]=[C:16]([F:17])[C:11]3=[N:10][C:9]=2[C:18]2[CH:19]=[C:20]([CH:32]=[CH:33][CH:34]=2)[C:21]([NH:23][C:24]2[C:29]([F:30])=[CH:28][CH:27]=[CH:26][C:25]=2[F:31])=[O:22])[CH:5]=[CH:4][N:3]=1.[N:35]1([CH:41]2[CH2:46][CH2:45][N:44]([C:47]3[CH:53]=[CH:52][C:50]([NH2:51])=[C:49]([O:54][CH3:55])[CH:48]=3)[CH2:43][CH2:42]2)[CH2:40][CH2:39][CH2:38][CH2:37][CH2:36]1.O.C1(C)C=CC(S(O)(=O)=O)=CC=1.C[O-].[Na+]>FC(F)(F)CO.CO.C(Cl)Cl.CCCCCC>[N:35]1([CH:41]2[CH2:46][CH2:45][N:44]([C:47]3[CH:53]=[CH:52][C:50]([NH:51][C:2]4[N:7]=[C:6]([C:8]5[N:12]6[CH:13]=[CH:14][CH:15]=[C:16]([F:17])[C:11]6=[N:10][C:9]=5[C:18]5[CH:19]=[C:20]([CH:32]=[CH:33][CH:34]=5)[C:21]([NH:23][C:24]5[C:29]([F:30])=[CH:28][CH:27]=[CH:26][C:25]=5[F:31])=[O:22])[CH:5]=[CH:4][N:3]=4)=[C:49]([O:54][CH3:55])[CH:48]=3)[CH2:43][CH2:42]2)[CH2:40][CH2:39][CH2:38][CH2:37][CH2:36]1Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 4
Conditions
- Temperature
- 145 °C
Procedure
To 3-[3-(2-chloro-4-pyrimidinyl)-8-fluoroimidazo[1,2-a]pyridin-2-yl]-N-(2,6-difluoro-phenyl)benzamide (Example 188, step A) (100 mg, 0.21 mmol) and 4-(1,4′-bipiperidin-1′-yl)-2-(methyloxy)aniline (Example 22, step C) (54 mg, 0.19 mmol) in 2,2,2-trifluoroethanol (2 mL) was added p-toluenesulfonic acid monohydrate (95 mg, 0.50 mmol). The mixture was stirred and heated on a microwave at 145° C. for 30 min, then cooled to rt. The mixture was neutralized with 0.5M sodium methoxide in MeOH. The mixture was concentrated under vacuum and the residue purified by silica gel chromatography to give a yellow solid. The solid was dissolved in minimal DCM, then hexane was added until a precipitate was formed. The slurry was cooled at −10° C. for 30 min, then poured through a Teflon filter, washing the solids with cold hexanes. The solids were dried under vacuum to give the title compound (90 mg, 0.12 mmol, 66%) as a yellow solid. 1H NMR (400 MHz, DMSO-d6): δ 10.26 (s, 1H), 9.20 (br s, 1H), 8.52 (s, 1H), 8.34 (s, 1H), 8.24 (d, 1H, J=5.13 Hz), 8.07 (d, 1H, J=7.88 Hz), 7.83 (d, 1H, J=7.70 Hz), 7.62 (t, 1H, J=7.79 Hz), 7.34-7.45 (m, 3H), 7.21 (t, 2H, J=8.06 Hz), 6.93-6.99 (m, 1H), 6.66 (d, 1H, J=2.20 Hz), 6.45-6.50 (m, 2H), 3.79 (s, 3H), 3.70-3.77 (m, 2H), 2.59-2.68 (m, 2H), 2.42-2.48 (m, 4H), 2.28-2.37 (m, 1H), 1.76-1.83 (m, 2H), 1.35-1.60 (m, 8H). MS (ESI): 733 [M+H]+.
Workup
- temperaturecooled to rt
- concentrationThe mixture was concentrated under vacuum
- customthe residue purified by silica gel chromatography
- customto give a yellow solid
- customwas formed
- temperatureThe slurry was cooled at −10° C. for 30 min
- filtrationfilter
- washwashing the solids with cold hexanes
- customThe solids were dried under vacuum
Sources & evidence
- ORD record
- ord-41828abd178f459cb17a0ed3ee812f2d
- Source dataset
- uspto-grants-2012_01
- Patent number
- US08093239B2
Reaction notes
Loading…